COMPANY PROFILE · /terray-therapeutics
T
Terray Therapeutics
AI-first small-molecule drug discovery platform using machine learning to explore chemical space faster. Founded by Stripe co-founder Patrick Collison and biotech veterans, combining generative chemistry with traditional pharmacology workflows.
Fresh · 9d ago
Latest valuation
—
Annual Recurring Revenue
—
Headcount
—
Funding total
$195 million
OVERVIEW
Raised $120M Series B in October 2025 (Bedford Ridge led, Nvidia NVentures participated); prior $75M Series A in 2023. Bridges preclinical to clinical stage.
Status
active
Tier
master-list
Profitability
—
Pricing
enterprise
FUNDING HISTORY · 0
No funding rounds on file.
PRODUCTS · 0
No products catalogued yet. Press Refresh above to ask the research agent.
TEAM · 0 key people
No people linked.
SOURCES · 0 cited
No citations stored yet. Run the research agent to attach per-claim sources.